"While typically a minor inconvenience, iodide mumps can present with severe, life-threatening complications, underscoring the need for increased clinical awareness and refined diagnostic approaches."
A recent case report detailing a 37-year-old woman’s severe reaction to iodinated contrast dye, leading to airway compromise and prolonged ventilation, has brought renewed attention to a condition known as iodide mumps. Traditionally considered a harmless and transient side effect, this swelling of the salivary glands after the administration of contrast agents, commonly used in medical imaging, can, in rare instances, escalate to critical levels. This alarming development prompts a deeper examination of the condition’s pathophysiology, diagnostic challenges, and potential implications for patient care, particularly in the context of its potential underreporting.
Iodide mumps, a condition characterized by the enlargement of the salivary glands, most commonly the parotid and submandibular glands, following exposure to iodinated contrast media, is typically self-limiting and resolves within a few days without intervention. However, the experience of a 37-year-old woman, who required intubation and three days on a ventilator due to extreme swelling of her salivary glands after a brain-vein procedure, starkly illustrates that the condition can indeed pose significant risks. This case, published in the American Journal of Case Reports by neurologists from the University of Wisconsin-Madison, serves as a critical reminder that seemingly benign reactions can harbor serious underlying mechanisms. The report is not an isolated incident; it joins a growing body of literature this year, including a case linked to facial iodine iontophoresis—a therapeutic technique employing electric current to enhance iodine absorption through the skin. These recurring reports suggest that iodide mumps may be more prevalent than currently recognized, urging healthcare professionals to maintain a high index of suspicion when patients present with neck swelling post-contrast procedures.
The woman in question was diagnosed with idiopathic intracranial hypertension, a neurological disorder characterized by elevated pressure within the skull, necessitating a cerebral angiogram followed by a venous sinus stenting procedure. Both interventions involved the administration of approximately 170 milliliters of iopamidol, a widely used iodinated contrast agent. The onset of symptoms was remarkably rapid; within three hours of the stenting procedure, the patient experienced painful swelling in her right parotid and submandibular glands. This swelling progressively impeded her ability to swallow and breathe, forcing her to rely on accessory muscles for respiration. The severity of her distress necessitated immediate intubation and mechanical ventilation, which she required for three days. Subsequent CT imaging confirmed significant swelling in the affected salivary gland regions. Medical management involved a course of potent anti-inflammatory and supportive medications, including methylprednisolone, diphenhydramine, and epinephrine, followed by dexamethasone and a gradual steroid taper over two weeks. Fortunately, her condition stabilized, and the swelling substantially resolved. Importantly, her renal function remained unimpaired throughout the ordeal, as evidenced by a stable creatinine level of 0.8 mg/dL, a finding that challenges prior assumptions about the condition’s direct link to compromised kidney function.
The substantial iodine load administered during the procedures is a key factor in understanding the pathophysiology of iodide mumps. The authors estimated that the 171 milliliters of contrast used in the stenting procedure contained approximately 8,550 micrograms of free iodine, a quantity exceeding 50 times the recommended daily intake. While contrast agents are engineered to bind iodine tightly, a small fraction of free iodine inevitably enters the bloodstream. Salivary glands possess a remarkable capacity to concentrate iodine, absorbing it from the serum at levels 20 to 100 times higher than circulating concentrations. This accumulation of excess iodine is believed to trigger an inflammatory response within the glands, leading to the characteristic swelling.
Historically, iodide mumps has been closely associated with impaired renal function. The kidneys are the primary route for iodine excretion, with approximately 98% of iodine being cleared through this organ. Therefore, diminished kidney function can prolong the presence of iodine in the bloodstream, increasing the likelihood of its absorption by salivary glands. However, the case of the 37-year-old woman, who maintained normal kidney function, along with findings from a 2020 meta-analysis of published cases, demonstrates that compromised renal function is not a prerequisite for developing iodide mumps. This analysis revealed that only 39% of patients with iodide mumps exhibited a creatinine level above 1.1 mg/dL, indicating that individuals with healthy kidneys are also susceptible. The age range of documented cases spans from 8 to 80 years, with a median age of 63. While the majority of reported cases (approximately 85%) involve bilateral swelling, this particular patient experienced unilateral enlargement, highlighting the variability in clinical presentation.
The rarity of documented cases, with only 77 confirmed reports as of 2020 despite the administration of over 75 million doses of iodinated contrast worldwide, has led researchers to propose that the condition may be significantly underreported. This underdiagnosis could stem from several factors, including a lack of familiarity among clinicians and the potential for misinterpretation of symptoms. Evidence supporting this hypothesis comes from an observational study where otolaryngology specialists, trained to recognize iodide mumps, identified four cases within two months, whereas emergency physicians without specialized training in the same population identified none. The delay in symptom onset—often occurring hours after a contrast scan—can lead to the condition being mistaken for more common ailments such as infections, salivary stones, or allergic reactions. Diagnostic imaging, such as CT scans, can reveal symmetric enlargement of the salivary glands without evidence of cysts or focal lesions, which can aid in diagnosis. Furthermore, recurrent episodes of iodide mumps following repeated contrast administration have been documented, as reported in the Annals of Internal Medicine, suggesting that some individuals may have a predisposition to this reaction.
While prevention strategies remain largely speculative, suggestions such as consuming sour candy, maintaining adequate hydration, and performing saline gargles have been proposed, though none have demonstrated definitive efficacy in reducing symptom duration. The Wisconsin case introduced a novel aspect to the understanding of iodide mumps. While generally attributed to iodine accumulation rather than a classical allergic response, this patient’s skin prick test yielded a strong positive reaction specifically to iopamidol, with negative results for iohexol, another iodinated contrast agent. This finding suggests a selective sensitivity to iopamidol, potentially involving an immune-mediated component in this specific instance. The authors advocate for targeted skin testing to identify specific contrast agents that trigger such reactions, thereby enabling the selection of safer alternatives for future imaging procedures. This personalized approach is crucial, as a broad diagnosis of "contrast allergy" could unnecessarily preclude patients from receiving essential imaging studies. In this patient’s case, the testing indicated iohexol as a potentially safer option, although her subsequent management with this agent was not detailed in the report.
It is important to acknowledge that a single case report cannot definitively elucidate the complex mechanisms of iodide mumps. While most episodes are mild and resolve spontaneously, any patient experiencing swelling of the salivary glands after a contrast scan should consult a healthcare professional. Symptoms indicative of airway compromise, such as difficulty breathing or swallowing, warrant immediate emergency medical attention. The ability to differentiate between iodine accumulation and a potential immune-mediated sensitivity through targeted testing could significantly improve patient safety and guide future clinical decisions, ensuring that necessary diagnostic procedures can be performed with minimized risk. The experience of this woman underscores the critical need for clinicians to remain vigilant for iodide mumps, even in its less common, severe presentations, and to consider personalized diagnostic approaches when managing patients with potential contrast sensitivities.
